EPSMomentum

$ARWR with a neutral outlook following its earning release

NASDAQ:ARWR   Arrowhead Pharmaceuticals, Inc.
$ARWR released its earnings with a negative under reaction following its announcement with the PEAD projecting a neutral outlook and placing the stock in Drift D

If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.


Professional grade tools including Earning momentum and Post earning announcement drift price forecast. www.epsmomentum.com
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。